Population pharmacokinetic study of isepamicin with intensive care unit patients.
The pharmacokinetics (PK) of isepamicin, a new aminoglycoside, were studied in 85 intensive care unit (ICU) patients and were compared with those observed in 10 healthy volunteers. A parametric method based on a nonlinear mixed-effect model was used to assess population PK. Isepamicin was given intr...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1996
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163243/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8849264/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.4.983 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
